InsiderTrades

Form 4 for IMCR Immunocore Holdings plc

Accepted 2024-04-03 00:00:00 ET · period of report 2024-04-01 · accession 0001415889-24-009989 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-04-03 2024-04-01 IMCR St Leger Tina Amber Chief HR Off M - OptEx $29.87 +4,375 4,375 New +$130.7K
D 2024-04-03 2024-04-01 IMCR St Leger Tina Amber Chief HR Off S - Sale+OE $64.06 -4,375 0 -100% -$280.3K
D 2024-04-03 2024-04-01 IMCR St Leger Tina Amber Chief HR Off M - OptEx $0.00 -4,375 35.0K -11% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Ordinary Shares 2024-04-01 M A 4,375 $29.87 4,375 D — —
2 Common Ordinary Shares 2024-04-01 S D 4,375 $64.06 0 D — — (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.73 to $64.08 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3 Derivative Employee Share Option (Right to Buy) 2024-04-01 M D 4,375 $0.00 35,000 D $29.87 · — to 2032-03-31 4,375 Ordinary Shares (F3) 25% of the shares subject to the option award vested on April 1, 2023, and 6.25% of the shares subject to the option award vested or shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.